Alterity Therapeutics Ltd.ASX: ATH

PBT434 Lowers Alpha-Synuclein and Prevents Neurodegeneration

Jul 3, 2017 at 5:02 AM UTC · Issued by Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd has released a press release.

View Attachment